Business
HCi Viocare awarded Start-Up Grant for the 10th International Conference on Advanced Technologies & Treatments for Diabetes
HCi Viocare awarded Start-Up Grant for the 10th International Conference on Advanced Technologies & Treatments for Diabetes.
About this update from Rafina Innovations Inc.
[{"type":"text","content":"\n \n \n HCi Viocare awarded Start-Up Grant for the 10th International Conference on Advanced Technologies & Treatments for Diabetes\n \n \nHCi Viocare awarded Start-Up Grant for the 10th International Conference on Advanced Technologies & Treatments for Diabetes\n \n GLASGOW, SCOTLAND--(Marketwired - Nov 7, 2016) -  HCi Viocare (OTCQB: VICA), is pleased to announce that its wholly owned subsidiary HCi Viocare Technologies is the winner of a Startup Grant for the Technology Fair at the 10th International Conference on Advanced Technologies & Treatments for Diabetes(ATTD), taking place in Paris, France, February 15th-18th, 2017. The Company has been recognized for its contribution to the development of innovative solutions in the diabetes prevention and treatment fields. \n ATTD's impact\n Over the past 9 years, the International Conference of ATTD has become synonymous with top caliber scientific programs that have provided participants with cutting edge research and analysis into the latest developments in diabetes-related technology.\n 2,645 participants from 80 countries\n A unique and innovative conference, the ATTD Conference attracts the world's leading researchers, clinical practitioners and industry/corporate professionals for a lively exchange of ideas and information related to the technology, treatment and prevention of diabetes and related illnesses.\n HCi Viocare's distinction\n HCi Viocare has been distinguished for its innovative solution which addresses important gaps in the diabetes care field. The Company's sensors can revolutionize diabetic foot monitoring and ulceration prevention. The ground breaking pressure and shear sensing technology, Flexisense™, can help people with diabetes monitor their feet in order to prevent ulcerations that can lead to amputation. The patented Flexisense™ technology uses a multitude of micro sensors to detect pressure as well as shear, that is unique over other sensing technologies. The sensors are wirelessly connected to smart devices providing real time and on demand information.\n HCi Viocare's awarded participation at the ATTD Conference include a booth in which the Company will demonstrate the unique features of the Flexisense™ Smart Insole, and a related presentation at the Technology Fair.\n HCi Viocare's co-founder and CTO...